Ventas (NYSE:VTR) has been given a $50.00 price target by KeyCorp in a note issued to investors on Thursday. The brokerage presently has a “sell” rating on the real estate investment trust’s stock. KeyCorp’s price objective would indicate a potential downside of 8.81% from the company’s previous close. KeyCorp also issued estimates for Ventas’ Q4 2017 earnings at $1.02 EPS, FY2017 earnings at $4.10 EPS and Q1 2018 earnings at $1.01 EPS.
Several other brokerages have also issued reports on VTR. Bank of America lowered Ventas from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $72.00 to $71.00 in a research report on Friday, September 22nd. Capital One Financial assumed coverage on Ventas in a research report on Monday, September 25th. They set an “equal weight” rating and a $69.00 target price for the company. UBS Group lowered their target price on Ventas from $69.00 to $66.00 and set a “neutral” rating for the company in a research report on Monday, October 2nd. Zacks Investment Research lowered Ventas from a “hold” rating to a “sell” rating in a research report on Wednesday, November 15th. Finally, Raymond James Financial reaffirmed an “underperform” rating on shares of Ventas in a research report on Monday, December 4th. Eight investment analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company’s stock. Ventas currently has a consensus rating of “Hold” and an average price target of $63.89.
Shares of Ventas (NYSE:VTR) traded down $1.40 during trading hours on Thursday, reaching $54.83. The company had a trading volume of 4,282,619 shares, compared to its average volume of 1,887,627. The company has a market cap of $20,027.09, a price-to-earnings ratio of 16.82, a P/E/G ratio of 3.76 and a beta of 0.09. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.46 and a current ratio of 1.46. Ventas has a twelve month low of $54.77 and a twelve month high of $72.36.
Hedge funds have recently bought and sold shares of the company. Amica Retiree Medical Trust bought a new position in shares of Ventas in the 3rd quarter worth about $131,000. Cable Hill Partners LLC bought a new position in shares of Ventas in the 3rd quarter worth about $174,000. Carnick & Kubik Group LLC bought a new position in shares of Ventas in the 3rd quarter worth about $204,000. Vident Investment Advisory LLC bought a new position in shares of Ventas in the 3rd quarter worth about $206,000. Finally, AlphaStar Capital Management LLC bought a new position in shares of Ventas in the 3rd quarter worth about $209,000. 90.01% of the stock is owned by hedge funds and other institutional investors.
Ventas, Inc is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses.
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.